Working… Menu

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04539262
Recruitment Status : Completed
First Posted : September 4, 2020
Last Update Posted : April 9, 2021
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 26, 2021
Actual Study Completion Date : March 22, 2021